Carvedilol, a Non-Selective β-with α1-Blocker is Effective in Long QT Syndrome Type 2

Carvedilol, a Non-Selective β-with α1-Blocker is Effective in Long QT Syndrome Type 2

Background: β-blockers offer the first line therapy in congenital long QT syndrome (LQTS), and are more effective to prevent the cardiac event in LQTS type 1 than in type 2 or 3. In contrast, left cardiac sympathetic denervation (LCS D) was shown to be highly effective in patients refractory to β-bl...

Full description

Bibliographic Details
Main Authors: Hiromi Kimura, MD, Yuka Mizusawa, MD, Hideki Itoh, MD, Akashi Miyamoto, MD, Mihoko Kawamura, MD, Tamiro Kawaguchi, MD, Nobu Naiki, MD, Yuko Oka, MD, Seiko Ohno, MD, Takeru Makiyama, MD, Makoto Ito, MD, Minoru Horie, MD
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Arrhythmia
Subjects:
Long QT syndrome
β-blocker therapy
carvedilol
α-adrenoceptor
Online Access:http://www.sciencedirect.com/science/article/pii/S1880427611800347

Internet

http://www.sciencedirect.com/science/article/pii/S1880427611800347

Similar Items